Fast Five Quiz: Breast Cancer Treatment

Pavani Chalasani, MD, MPH


July 12, 2021

Figure 1. Colored MRI of a section through a 58-year-old woman's left breast, showing a malignant adenocarcinoma (tumor, dark) and tissue damage.

Tumor gene-expression assays can determine the likelihood of recurrence in early-stage breast cancer and thus the potential benefit of adjuvant chemotherapy. Lower scores indicate a prognostic recurrence rate that is unlikely to be improved by adjuvant chemotherapy. A higher score, however, can be predictive of chemotherapy benefit. Adjuvant therapy involves radiation and systemic therapy, which includes a variety of chemotherapeutic, hormonal, and biologic agents.

Needle biopsy, mammogram, and MRI are all tools that may be used in the diagnosis of breast cancer.

Learn more about determining the potential benefit of adjuvant chemotherapy for breast cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.